ent-Galanthamine | CAS# 60384-53-4 | Enantiomer

MedKoo Cat#: 574704 | Name: ent-Galanthamine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ent-Galanthamine is the (+) enantiomer of Galanthamine.

Chemical Structure

ent-Galanthamine

CAS#60384-53-4

Theoretical Analysis

MedKoo Cat#: 574704

Name: ent-Galanthamine

CAS#: 60384-53-4

Chemical Formula: C17H21NO3

Exact Mass: 287.1521

Molecular Weight: 287.36

Elemental Analysis: C, 71.06; H, 7.37; N, 4.87; O, 16.70

Price and Availability

Size	Price	Availability	Quantity

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

ent-Galanthamine; (+)-Galanthamine; Galantamine, (+)-; Galanthamine, (+)-;

IUPAC/Chemical Name

(4aS,6S,8aR)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol

InChi Key

ASUTZQLVASHGKV-HACGYAERSA-N

InChi Code

InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14+,17-/m1/s1

SMILES Code

COC1=CC=C2C3=C1O[C@H]4C[C@H](O)C=C[C@]34CCN(C)C2

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 287.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Fulton B, Benfield P. Galanthamine. Drugs Aging. 1996 Jul;9(1):60-5; discussion 66-7. doi: 10.2165/00002512-199609010-00006. PMID: 8818586. 2: Cozanitis DA, Toivakka E. Galanthamine. JAMA. 1978 Jul 14;240(2):108. doi: 10.1001/jama.240.2.108b. PMID: 660819. 3: Marco L, do Carmo Carreiras M. Galanthamine, a natural product for the treatment of Alzheimer's disease. Recent Pat CNS Drug Discov. 2006 Jan;1(1):105-11. doi: 10.2174/157488906775245246. PMID: 18221196. 4: Stanilova MI, Molle ED, Yanev SG. Galanthamine production by Leucojum aestivum cultures in vitro. Alkaloids Chem Biol. 2010;68:167-270. doi: 10.1016/s1099-4831(10)06805-7. PMID: 20334039. 5: Heinrich M. Galanthamine from Galanthus and other Amaryllidaceae--chemistry and biology based on traditional use. Alkaloids Chem Biol. 2010;68:157-65. doi: 10.1016/s1099-4831(10)06804-5. PMID: 20334038. 6: Sanyal R, M M, Pandey S, Nandi S, Biswas P, Dewanjee S, Gopalakrishnan AV, Jha NK, Jha SK, Joshee N, Pandey DK, Dey A, Shekhawat MS. Biotechnological interventions and production of galanthamine in Crinum spp. Appl Microbiol Biotechnol. 2023 Apr;107(7-8):2155-2167. doi: 10.1007/s00253-023-12444-0. Epub 2023 Mar 16. PMID: 36922438. 7: Gulcan HO, Orhan IE, Sener B. Chemical and molecular aspects on interactions of galanthamine and its derivatives with cholinesterases. Curr Pharm Biotechnol. 2015;16(3):252-8. doi: 10.2174/1389201015666141202105105. PMID: 25483718. 8: Harvey AL. The pharmacology of galanthamine and its analogues. Pharmacol Ther. 1995;68(1):113-28. doi: 10.1016/0163-7258(95)02002-0. PMID: 8604434. 9: Heinrich M, Lee Teoh H. Galanthamine from snowdrop--the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J Ethnopharmacol. 2004 Jun;92(2-3):147-62. doi: 10.1016/j.jep.2004.02.012. PMID: 15137996. 10: López-Pousa S, Garre-Olmo J, Vilalta-Franch J. Galantamina frente a donepecilo en el tratamiento de la enfermedad de Alzheimer [Galanthamine versus donepezil in the treatment of Alzheimer's disease]. Rev Neurol. 2007 Jun 1-15;44(11):677-84. Spanish. PMID: 17557224. 11: Fraser MD, Vallin HE, Davies JRT, Rowlands GE, Chang X. Integrating Narcissus-derived galanthamine production into traditional upland farming systems. Sci Rep. 2021 Jan 14;11(1):1389. doi: 10.1038/s41598-021-81042-9. PMID: 33446764; PMCID: PMC7809449. 12: Sramek JJ, Frackiewicz EJ, Cutler NR. Review of the acetylcholinesterase inhibitor galanthamine. Expert Opin Investig Drugs. 2000 Oct;9(10):2393-402. doi: 10.1517/13543784.9.10.2393. PMID: 11060814. 13: Xiong Z, Weidlich F, Sanchez C, Wirth T. Biomimetic total synthesis of (-)-galanthamine via intramolecular anodic aryl-phenol coupling. Org Biomol Chem. 2022 May 26;20(20):4123-4127. doi: 10.1039/d2ob00669c. PMID: 35537211. 14: Keglevich P, Szántay C, Hazai L. The Chemistry of Galanthamine. Classical Synthetic Methods and Comprehensive Study on its Analogues. Mini Rev Med Chem. 2016;16(18):1450-1461. doi: 10.2174/1389557516666160321114556. PMID: 26996619. 15: Cozanitis DA. The snowdrop, wellspring of galanthamine : A brief descriptive and scientific history. Wien Med Wochenschr. 2021 Jun;171(9-10):205-213. doi: 10.1007/s10354-020-00799-2. Epub 2021 Jan 27. PMID: 33502637. 16: Miller IR, McLean NJ, Moustafa GAI, Ajavakom V, Kemp SC, Bellingham RK, Camp NP, Brown RCD. Transition-Metal-Mediated Chemo- and Stereoselective Total Synthesis of (-)-Galanthamine. J Org Chem. 2022 Jan 21;87(2):1325-1334. doi: 10.1021/acs.joc.1c02638. Epub 2022 Jan 10. PMID: 35007075. 17: Majumder S, Yadav A, Pal S, Khatua A, Bisai A. Asymmetric Total Syntheses of (-)-Lycoramine, (-)-Lycoraminone, (-)-Narwedine, and (-)-Galanthamine. J Org Chem. 2022 Jun 17;87(12):7786-7797. doi: 10.1021/acs.joc.2c00420. Epub 2022 May 25. PMID: 35613361. 18: Snorrason E, Stefánsson JG. Galanthamine hydrobromide in mania. Lancet. 1991 Mar 2;337(8740):557. doi: 10.1016/0140-6736(91)91347-w. PMID: 1671920. 19: López S, Bastida J, Viladomat F, Codina C. Galanthamine pattern in Narcissus confusus plants. Planta Med. 2003 Dec;69(12):1166-8. doi: 10.1055/s-2003-818013. PMID: 14750039. 20: Dal-Bianco P, Maly J, Wôber C, Lind C, Koch G, Hufgard J, Marschall I, Mraz M, Deecke L. Galanthamine treatment in Alzheimer's disease. J Neural Transm Suppl. 1991;33:59-63. doi: 10.1007/978-3-7091-9135-4_10. PMID: 1753253.